Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

    • Cancer
    • Lung Cancer
    • Non-Small Cell Lung Cancer (NSCLC)
    • Non Small Cell Lung Carcinoma